Skip to main content
Full access
REGULAR
Published Online: 1 October 2008

Impaired Reproduction of Three-Dimensional Objects by Cocaine-Dependent Subjects

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
C ocaine dependence is a resurgent public health problem that afflicts over 1.5 million American citizens; cocaine is the most prevalent illicit drug detected on blood and urine toxicology screens performed in U.S. emergency rooms. 1 Neuropsychologically, cocaine-dependent patients demonstrate a mild to moderate degree of impairment in such cognitive areas as attention, working memory, learning and memory, and executive functions. 212 These impairments have been linked in some, 8, 11 but not in all, 7 studies to functional and morphological alterations in (pre)frontal brain regions. 6, 9, 11
Constructional tasks, such as drawing various figures and shapes, are other neuropsychological assessment tools that are particularly sensitive for detection of early or subtle brain damage. 13 Although constructional ability is traditionally assessed within the context of a neurological examination, 13 it is a high-level cognitive function, integrating a complex system of interrelated visual, motor and executive capacities, each of which exhibits a unique role within the context of perceptual/motor behavior. To our knowledge, this has not yet been attempted in cocaine-dependent individuals.
A routine way of assessing constructional ability is through the Copy Figure Test, comprising two- and three-dimensional figures. Such a design offers a more precise interpretation of the findings, that is to say, if a subject inadequately copies both two- and three-dimensional images, it may be inferred that failed performance is not secondary to impaired perception of tridimensionality, and a case for a basic constructional deficit is supported. On the other hand, a control level performance on two-dimensional figures suggests that both eyesight and the ability to translate visual images into kinesthetic concepts and then into motor actions 13 are preserved, and that performance differences are due to three-dimensional processing. In addition, the Copy Figure Test eliminates memory involvement by having the figure to be copied in front of the subject at all times. 13, 14 Furthermore, the test is relatively independent of age, educational status, and intelligence: the ability to copy the figures is fully acquired by the age of 12; older age brackets (ages 40–60) retain normal and unaltered results. 13
Consistent with prior reports on neurocognitive impairments, 4, 7, 8, 11, 12 including visuoperceptual deficits, 3, 5, 10 we hypothesized that individuals with cocaine dependence, relative to healthy comparison subjects, would display compromised Copy Figure Test performance. As a second comparison group, we enrolled subjects with marijuana abuse or dependence, who also were not expected to be impaired. 15
METHODS
Twenty-seven subjects meeting DSM-IV-TR criteria for cocaine dependence, 26 subjects meeting DSM-IV-TR criteria for marijuana dependence or abuse, and 33 mentally healthy subjects were recruited by advertisement and participated in this study after giving written informed consent. The protocol was approved by the McLean Hospital Institutional Review Board. All subjects were in good physical health and had no history of head injury, loss of consciousness, brain tumor, seizures, or cerebrovascular accident, as determined by neurological screening and by the Cornell Medical Index Health Questionnaire. 16 Education about the effects of the drugs was provided, and referral to drug treatment programs was offered, when appropriate.
Each subject underwent the Structured Clinical Interview for DSM-IV-TR Axis I Disorders. 17 Active cocaine or marijuana use was confirmed by urinalysis; subjects with urine toxicology screens positive for other substances were excluded. Cocaine dependent subjects with a history of any other axis I psychiatric diagnosis, including other substance dependence (but not abuse), were also excluded. Of the 26 marijuana dependence (n=12) or abuse (n=14) subjects, five had a comorbid diagnosis of major depression and four were alcohol dependent. Number of drinks in the week before the study appears in Table 1 . Cocaine-dependent subjects were not seeking or participating in addiction treatment. They had used cocaine for a mean duration±standard deviation (SD) 15.1±6.9 years, with a frequency of 4.4±2.2 times in the week before the study, and last use was at least 24 hours prior to the study. Marijuana abuse/dependence subjects had smoked this substance for 7.0±5.9 years, with a frequency of 6.6±0.7 times in the week before the study.
TABLE 1. Demographic and Clinical Characteristics (Means±SDs or Ratios) of Study Participants
Subjects were instructed to copy each figure ( Figure 1 ) exactly as it looked to them with a pen. They were further told to make only one attempt at each figure, even if they were not completely satisfied with the result, and not to erase any lines or draw any additional lines that did not appear in the original figure. There were no time limits. A dually trained psychiatrist and neurologist (TVG), who not only was blind to the diagnosis but had never seen the subjects, scored each figure on the following Likert-type scale: 0=near perfect reproduction; 1=mild distortion or rotation; 2=moderate distortion or rotation, micropsy, or loss of three-dimensionality; and 3=gross distortion of the basic gestalt (i.e., figure virtually unrecognizable).
FIGURE 1. Figures Used in Copy Figure Test
A. Two-dimensional (diamond and cross) and three-dimensional (Necker cube, smoking pipe, hidden line elimination cube, pyramid and dissected pyramid) figures to be copied by the subjects. B. Examples of cocaine-dependent subjects’ performance on the Copy Figure Test.
Demographic variables were analyzed with analyses of variance (ANOVAs) or chi-square. Overall Copy Figure Test results were analyzed by means of a two-factor analysis of covariance (ANCOVA), with diagnosis (cocaine dependence, marijuana dependence/abuse, or mentally healthy) as a between-subjects factor; figure type (diamond, cross, Necker cube, smoking pipe, hidden line elimination cube, pyramid and dissected pyramid) as a within-subjects factor; and age, education, current number of drinks per week, and race (white or black) as covariates. Additionally, one-factor ANCOVAs were performed separately for each figure, followed by post hoc Scheffe tests when the group effect was significant. The Pearson correlation coefficient was used for correlative analyses. All analyses were two-tailed, and significance was defined as p<0.05.
The rationale for combining marijuana dependence and abuse data was as follows: a higher diagnostic threshold for marijuana dependence due to the lack of a DSM-IV-TR marijuana withdrawal criterion, and no significant differences between marijuana dependence and abuse subgroups on any of the figures (p>0.35).

RESULTS

As presented in Table 1, cocaine-dependent subjects were significantly older, were less educated, drank more alcohol, and were more likely to be black than both marijuana users and healthy comparison subjects. Marijuana users were significantly younger, were less educated, and drank less than healthy comparison subjects. Gender distribution was not significantly different among the groups.
Figure 1 presents examples of mistakes made by cocaine-dependent subjects. The raw group means for each item on the Copy Figure Test are displayed in Figure 2 . Two-factor ANCOVA yielded a significant diagnosis main effect (F=11.35, df=2, 78, p<0.0001) and a significant diagnosis by figure type interaction (F=2.65, df=12, 468, p=0.002). Table 2 presents the adjusted group means for each figure separately, along with results of the univariate ANCOVAs and significant pairwise group differences.
FIGURE 2. Raw Group Means (±SDs) for the Individual Copy Figure Test Items
TABLE 2. Adjusted Group Means (±SDs) for the Individual Copy Figure Test Items
It may be seen that there was no significant group effect on copying two-dimensional figures (diamond and cross). For the three-dimensional figures, there were highly significant differences between cocaine-dependent subjects (worse performance) versus healthy and marijuana-dependent subjects on the Necker cube, smoking pipe, and dissected pyramid, and between cocaine-dependent subjects versus healthy subjects on the hidden line elimination cube and pyramid. The most significant difference between the cocaine group and the other two groups was on the Necker cube, which is characterized by ambiguous front-back orientation necessitating visuospatial ability to shift attention between two equally plausible figural spatial representations. 18 Eighteen cocaine-dependent subjects (67%), one healthy subject (3%), and zero marijuana group subjects scored 3 (gross distortion of the basic gestalt) on at least one figure. There were no significant differences between healthy versus marijuana group subjects on any figure; indeed the performances of these two groups were highly comparable.
No correlations that approached statistical significance were found between age (r=0.04, df=25, p=0.85), education (r=−0.29, df=25, p=0.14), and the average Copy Figure Test score in the cocaine-dependent group, making these unlikely sources of diminished Copy Figure Test scores in this group, which were statistically adjusted for these factors.

DISCUSSION

To our knowledge, this is the first study to specifically assess constructional ability (i.e., capacity to draw two- and three-dimensional figures) in drug-dependent individuals. The major finding is that, notwithstanding the normal copying of two-dimensional figures, cocaine-dependent subjects, but not healthy or marijuana group subjects, displayed substantial impairment in copying three-dimensional figures. Sixty-seven percent of cocaine-dependent subjects, but almost no healthy or marijuana group subjects, showed a gross distortion of at least one figure, which is “almost pathognomonic” of brain damage. 13
In addition to its acute detrimental medical consequences, chronic cocaine use adversely affects its primary target organ, the brain, 19 with lacunar 20 and diffuse tissue reductions 21 as well as changes in cerebral perfusion and metabolism. 22 In light of this, it is tempting to conclude that the origin of the figure copying impairments found in this study is cocaine damage to the brain. However, it is also possible that a preexisting genetic 23 or acquired risk factor, which is manifest in impairment in copying figures, is imparting vulnerability for cocaine dependence in a similar manner to subtle neurological dysfunction in attention deficit hyperactivity disorder 24 as well as in victims of childhood abuse. 25 Resolving the origin of this impairment could require prospective and/or twin studies.
There is consistent clinical 26 and postmortem 27 evidence for a relationship between cocaine use and fatal injuries, with cocaine’s emergence as one of the five major causes of mortality among young people. 27 Cocaine-induced agitation and paranoia may certainly account for some violent deaths, 27 but the drug’s acute beneficial effects on attention and vigilance render it an unlikely direct reason for motor vehicle accidents. 28 Difficulties with spatial integration (along with other neurocognitive functions) as a consequence of long-term sustained cocaine use may be an alternate explanation, considering that decreased performance on copying a cube predicts motor vehicle crashes. 29
Several brain regions influence the drawing of three-dimensional figures, the most important of which appear to be parietal. 13 Specifically, patients with right parietal lobe lesions appear especially unable to reproduce the basic gestalt of such figures. 13 Seeking to tackle methodological limitations of early research on cortically damaged patients, Inui and colleagues 18 used functional MRI during the visual processing of cubes versus two-dimensional overlapping squares in a sample of healthy subjects and found symmetrical parietal area activations.
Ventral striatum and related mesolimbic dopaminergic circuitry are traditionally considered to be the key component of the reward system involved in cocaine dependence, and it is commonly hypothesized that cocaine-induced changes in the mesolimbic pathways underlying motivational processes are responsible for transforming regular drives into heightened incentive salience assigned to drugs or drug-related cues, such as incentive sensitization, clinically evident as craving. 30 However, recent work in primates suggests a novel factor in the mechanisms underlying incentive sensitization and craving by implicating the parietal cortex in the control exerted over striatal signals of salience via integration of visuospatial, motor, and cognitive (e.g., hedonic value and categorical boundaries) inputs. 31, 32 In addition to these theoretical considerations, an abundant clinical literature demonstrates parietal cortex changes in the context of chronic cocaine consumption. 23 There is a need to focus on this important region and its role in the pathophysiology of cocaine dependence.
A limitation of this study is that group differences in age, education, race, and alcohol use required us to perform statistical adjustments for these potentially confounding variables. Future studies should attempt group matching on these factors as far as possible within subject recruitment exigencies.
It is possible that the cocaine-dependent subjects may have underreported the extent of concomitant alcohol use, 33 which is common in these patients. Moreover, this study only quantified alcohol use during the previous week. Prior research has implicated alcohol in spatial disturbances. 34 However, none of the cocaine subjects fulfilled DSM-IV-TR criteria for past or current alcohol dependence. Additionally, it is unlikely that relatively mild alcohol consumption worsened cocaine-dependent subjects’ responses. If anything, alcohol tends to improve, or at least not to worsen, cognitive and visuospatial function in this group, 19, 20, 35, 36 perhaps via amelioration of cocaine’s acute vasoconstrictive effects. 37, 38 Nevertheless, a more thorough quantification of this important variable over a longer time period prior to testing, using instruments validated for this purpose, should be incorporated in future studies since chronic use of both cocaine and alcohol causes an enduring neurocognitive impairment, which ultimately might have an additive effect.
Finally, the paradigm employed does not allow us to firmly conclude that a higher-level constructional impairment is not implicated in the poorer three-dimensional figure copying observed in the cocaine-dependent subjects. Answering this question would require disentangling this component via an exclusively visual-processing paradigm that did not employ motoric output.
The present findings offer a new perspective on the pathophysiology of cocaine dependence. It should be noted that the test employed here is but one component of a 45-item battery of tests for neurological soft signs available for neuropsychiatric research. 39, 40 Even though the Copy Figure Test has proven to be the most sensitive tool in our prior work with posttraumatic stress disorder patients, 39, 40 the preset cocaine findings may not necessarily be specific to the deficits uncovered by the Copy Figure Test and could generalize to other neurological and/or cognitive impairments. Therefore, it would be revealing to perform a follow-up study that employs the full battery.

Acknowledgments

This work was supported by grant DA # 017959 (IE) from the National Institute on Drug Abuse.

Footnote

Received April 24, 2007; revised August 3 and September 6, 2007; accepted September 11, 2007. Drs. Elman, Chi, Ryan, and Lukas are affiliated with the Department of Psychiatry at McLean Hospital and Harvard Medical School; Drs. Gurvits, Lasko, and Pitman are affiliated with the Department of Psychiatry at Massachusetts General Hospital and Harvard Medical School. Address correspondence to Igor Elman, M.D., Department of Psychiatry, McLean Hospital/Harvard Medical School, 115 Mill St., Belmont, MA 02478-9106; [email protected] (e-mail).
Copyright © 2008 American Psychiatric Publishing, Inc.

References

1.
Vitale S, van de Mheen D: Illicit drug use and injuries: a review of emergency room studies. Drug Alcohol Depend 2006; 82:1–9
2.
Smelson DA, Roy A, Santana S, et al: Neuropsychological deficits in withdrawn cocaine-dependent males. Am J Drug Alcohol Abuse 1991; 25:377–381
3.
Ardila A, Rosselli M, Strumwasser S: Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57:73–79
4.
Strickland TL, Miller BL, Kowell A, et al: Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging. Neuropsychol Rev 1998; 8:1–9
5.
Di Sclafani V, Tolou-Shams M, Price LJ, et al: Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66:161–171
6.
Matochik JA, London ED, Eldreth DA, et al: Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003; 19:1095–1102
7.
Browndyke JN, Tucker KA, Woods SP, et al: Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. J Neuroimaging 2004; 14:162–169
8.
Goldstein RZ, Leskovjan AC, Hoff AL, et al: Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004; 42:1447–1458
9.
Bolla K, Ernst M, Kiehl K, et al: Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004; 16:456–464
10.
Kübler A, Murphy K, Garavan H: Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 2005; 21:1984–1992
11.
Jovanovski D, Erb S, Zakzanis KK: Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 2005; 27:189–204
12.
Verdejo-García A, Pérez-García M: Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007; 190:517–530
13.
Strub RL, Black FW: Constructional ability, in The Mental Status Examination in Neurology. Philadelphia, FA Davis Company, 2000, pp 93–114
14.
Luria AR: Higher Cortical Functions in Man. New York, Basic Books, 1966
15.
Lyons MJ, Bar JL, Panizzon MS, et al: Neuropsychological consequences of regular marijuana use: a twin study. Psychol Med 2004; 34:1239–1250
16.
Seymour GE: The structure and predictive ability of the Cornell Medical Index for a normal sample. J Psychosom Res 1976; 20:469–478
17.
First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York, Biometrics Research, N.Y. State Psychiatric Institute, 2002
18.
Inui T, Tanaka S, Okada T, et al: Neural substrates for depth perception of the Necker cube: a functional magnetic resonance imaging study in human subjects. Neurosci Lett 2000; 282:145–148
19.
Prakash A, Das G: Cocaine and the nervous system. Int J Clin Pharmacol Ther Toxicol 1993; 31:575–581
20.
Bartzokis G, Beckson M, Hance DB, et al: Magnetic resonance imaging evidence of “silent” cerebrovascular toxicity in cocaine dependence. Biol Psychiatry 1999; 45:1203–1211
21.
Fein G, Di Sclafani V, Meyerhoff DJ: Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine-dependent men. Drug Alcohol Depend 2002; 68:87–93
22.
Volkow ND, Fowler JS: Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10:318–325
23.
Majewska MD: Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res Monogr 1996; 163:1–26
24.
Volkow ND, Wang GJ, Newcorn J, et al: Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007; 34:1182–1190
25.
Green AH: Neurological impairment in maltreated children. Child Abuse Negl 1981; 5:129–134
26.
Marzuk PM, Tardiff K, Leon AC, et al: Prevalence of recent cocaine use among motor vehicle fatalities in New York City. JAMA 1990; 263:250–256
27.
Marzuk PM, Tardiff K, Leon AC, et al: Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med 1995; 332:1753–1757
28.
McBay AJ: Drugs and driving impairment. Available at http://www.druglibrary.org/schaffer/misc/driving/ddimp.htm
29.
Johansson K, Bronge L, Lundberg C, et al: Can a physician recognize an older driver with increased crash risk potential? J Am Geriatr Soc 1996; 44:1198–1204
30.
Berridge KC, Robinson TE: Parsing reward. Trends Neurosci 2003; 26:507–513
31.
Gottlieb J: From thought to action: the parietal cortex as a bridge between perception, action, and cognition. Neuron 2007; 53:9–16
32.
Freedman DJ, Assad JA: Experience-dependent representation of visual categories in parietal cortex. Nature 2006; 443:85–88
33.
Elman I, Krause S, Breiter HC, et al: The validity of self-reported drug use in non-treatment-seeking individuals with cocaine dependence: correlation with biochemical assays. Am J Addict 2000; 9:216–221
34.
Fein G, Torres J, Price LJ, et al: Cognitive performance in long-term abstinent alcoholic individuals. Alcohol Clin Exp Res 2006; 30:1538–1544
35.
Easton C, Bauer LO: Neuropsychological differences between alcohol-dependent and cocaine-dependent patients with or without problematic drinking. Psychiatry Res 1997; 71:97–103
36.
Robinson JE, Heaton RK, O’Malley SS: Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc 1999; 5:10–19
37.
Lawton-Craddock A, Nixon SJ, Tivis R: Cognitive efficiency in stimulant abusers with and without alcohol dependence. Alcohol Clin Exp Res 2003; 27:457–464
38.
Abi-Saab D, Beauvais J, Mehm J, et al: The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. Am J Addict 2005; 14:166–178
39.
Gurvits TV, Gilbertson MW, Lasko NB, et al: Neurologic soft signs in chronic posttraumatic stress disorder. Arch Gen Psychiatry 2000; 57:181–186
40.
Gurvits TV, Metzger LJ, Lasko NB, et al: Subtle neurologic compromise as a vulnerability factor for combat-related posttraumatic stress disorder: results of a twin study. Arch Gen Psychiatry 2006; 63:571–576

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 478 - 484
PubMed: 19196934

History

Published online: 1 October 2008
Published in print: Fall, 2008

Authors

Details

Tamara V. Gurvits, M.D., Ph.D.
Elizabeth T. Ryan, B.S.
Natasha B. Lasko, Ph.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share